Memoriam: Jack Calfee
The American Enterprise Institute has a very nice tribute to Jack Calfee, a respected pioneer in the health policy industry:
AEI mourns the passing of our colleague and friend Jack Calfee. Jack joined AEI in 1995 after a distinguished academic and government career. Although his recent writings have focused on pharmaceutical markets and Food and Drug Administration (FDA) regulation, he was also widely known for his work on patent law, tort liability,
advertising, and consumer information. A recent
article on advances in treating coronary heart
disease sounded a familiar Calfee theme when
he criticized unnecessary FDA requirements that
retard innovation and access to medical devices. His biography and published
work are posted here.
Jack will be missed. See also Benjamin Zycher’s kind words at National Review Online.
I have followed his work on the market for pharmaceuticals. He understood the economics of drug development like few others.
Nice tribute. He’ll be missed.
A significant loss.
When I got into health policy in 2000, my first projects focused on government intervention in prescription drugs: Patent law, the regulatory bureaucracy, restrictions on free speech (Direct-to-Consumer advertising, detailing physicians, et cetera).
Jack Calfee was the giant in this field: His thorough, accurate, and diligent research demolished any legitimate claim that the federal government should exercise undue interference over the actions of patients, doctors, or pharmaceutical innovators.
We need him today more than ever. Jack Calfee, RIP.
I loved as much as you will obtain carried out proper here. The cartoon is attractive, your authored subject matter stylish. nevertheless, you command get bought an nervousness over that you would like be handing over the following. in poor health certainly come more previously once more since precisely the similar nearly a lot incessantly inside of case you defend this hike.